Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Jul;93(1):93–96. doi: 10.1111/j.1365-2249.1993.tb06502.x

Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes.

A M Gerdes 1, M Hørder 1, V Bonnevie-Nielsen 1
PMCID: PMC1554756  PMID: 8324908

Abstract

2,5AS is induced by interferon-alpha, -beta (IFN-alpha, -beta) and polymerizes adenosine triphosphate (ATP) into pppA (2'p5'A) oligomers, leading to inhibition of protein synthesis and virus growth. The gene coding for the IFN-alpha, -beta receptor is localized to chromosome 21. In trisomy 21 cells from patients with Down's syndrome a 50% increase in gene dosage is present for the genes on this chromosome. Corresponding increase of gene products has been shown for several of these genes, e.g. the IFN-alpha, -beta receptor molecules. Here, we show a direct proportionality between the number of IFN-alpha, -beta receptors and both the basal activity of 2,5AS and the sensitivity of this enzyme for IFN-alpha, -beta. The relative increase of 2,5AS activity (the reactivity) becomes reduced consistent with the increased basal 2,5AS activity in trisomy 21 cells compared with control cells.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnevie-Nielsen V., Heron I., Kristensen T., Michelsen B., Lernmark A. Postimmunization activity of oligoadenylate synthetase in peripheral blood lymphocytes from healthy individuals. J Clin Lab Immunol. 1989 Apr;28(4):155–160. [PubMed] [Google Scholar]
  2. Bonnevie-Nielsen V., Larsen M. L., Frifelt J. J., Michelsen B., Lernmark A. Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes. 1989 Dec;38(12):1636–1642. doi: 10.2337/diab.38.12.1636. [DOI] [PubMed] [Google Scholar]
  3. Cupples C. G., Tan Y. H. Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome. Nature. 1977 May 12;267(5607):165–167. doi: 10.1038/267165a0. [DOI] [PubMed] [Google Scholar]
  4. Epstein C. J., McManus N. H., Epstein L. B., Branca A. A., D'Alessandro S. B., Baglioni C. Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor. Biochem Biophys Res Commun. 1982 Aug;107(3):1060–1066. doi: 10.1016/0006-291x(82)90629-5. [DOI] [PubMed] [Google Scholar]
  5. Epstein L. B., Lee S. H., Epstein C. J. Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect ot interferon. Cell Immunol. 1980 Mar 1;50(1):191–194. doi: 10.1016/0008-8749(80)90017-9. [DOI] [PubMed] [Google Scholar]
  6. Fujii N., Oguma K., Fujii M., Fukatsu R., Takahata N., Kitabatake M. Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy. Clin Exp Immunol. 1987 Apr;68(1):168–176. [PMC free article] [PubMed] [Google Scholar]
  7. Gerdes A. M., Hørder M., Bonnevie-Nielsen V. Gene dosage and down-regulation of the alpha-interferon receptor. Scand J Clin Lab Invest. 1992 May;52(3):189–192. doi: 10.3109/00365519209088784. [DOI] [PubMed] [Google Scholar]
  8. Gurari-Rotman D., Revel M., Tartakovsky B., Segal S., Hahn T., Handzel Z., Levin S. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon. FEBS Lett. 1978 Oct 15;94(2):187–190. doi: 10.1016/0014-5793(78)80934-x. [DOI] [PubMed] [Google Scholar]
  9. Langer J. A., Rashidbaigi A., Lai L. W., Patterson D., Jones C. Sublocalization on chromosome 21 of human interferon-alpha receptor gene and the gene for an interferon-gamma response protein. Somat Cell Mol Genet. 1990 May;16(3):231–240. doi: 10.1007/BF01233359. [DOI] [PubMed] [Google Scholar]
  10. Nurmi T., Huttunen K., Lassila O., Henttonen M., Säkkinen A., Linna S. L., Tiilikainen A. Natural killer cell function in trisomy-21 (Down's syndrome). Clin Exp Immunol. 1982 Mar;47(3):735–741. [PMC free article] [PubMed] [Google Scholar]
  11. Tan U. H. Chromosome-21-dosage effect on inducibility of anti-viral gene(s). Nature. 1975 Jan 24;253(5489):280–282. doi: 10.1038/253280a0. [DOI] [PubMed] [Google Scholar]
  12. Tan Y. H., Schneider E. L., Tischfield J., Epstein C. J., Ruddle F. H. Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Science. 1974 Oct 4;186(4158):61–63. doi: 10.1126/science.186.4158.61. [DOI] [PubMed] [Google Scholar]
  13. Weil J., Tucker G., Epstein L. B., Epstein C. J. Interferon induction of (2'-5') oligoisoadenylate synthetase in diploid and trisomy 21 human fibroblasts: relation to dosage of the interferon receptor gene (IRFC). Hum Genet. 1983;65(2):108–111. doi: 10.1007/BF00286644. [DOI] [PubMed] [Google Scholar]
  14. Williams B. R., Kerr I. M. Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells. Nature. 1978 Nov 2;276(5683):88–90. doi: 10.1038/276088a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES